Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

NextCure Publishes Non-Clinical Data Defining The Mechanism Of Action For NC525, A Novel LAIR-1 Antibody For AML

Author: Benzinga Newsdesk | November 15, 2023 05:11pm

New publication in Journal of Clinical Investigation provides compelling evidence for NC525's ability to specifically kill leukemic cells while sparing healthy cells in non-clinical modeling
Update for ongoing Phase 1a clinical trial is expected in the fourth quarter of 2023

Posted In: NXTC